TMEPAI promotes degradation of the NF-κB signaling pathway inhibitory protein IκBα and contributes to tumorigenesis

Int J Biol Macromol. 2023 Apr 30:235:123859. doi: 10.1016/j.ijbiomac.2023.123859. Epub 2023 Mar 1.

Abstract

The transmembrane prostate androgen-induced protein (TMEPAI) is known to be highly expressed in various types of cancer and promoted oncogenic abilities. However, the mechanisms whereby TMEPAI facilitates tumorigenesis are not fully understood. Here we reported that expression of TMEPAI activated the NF-κB signaling. TMEPAI showed direct interaction with NF-κB pathway inhibitory protein IκBα. Though ubiquitin ligase Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) did not interact with IκBα directly, TMEPAI recruited Nedd4 for ubiquitination of IκBα, leading to IκBα degradation through the proteasomal and lysosomal pathway, and promoted activation of NF-κB signaling. Further study indicated NF-κB signaling is involved in TMEPAI-induced cell proliferation and tumor growth in immune deficient mice. This finding helps to further understand the mechanism of TMEPAI on tumorigenesis and suggests TMEPAI is potential target for cancer treatment.

Keywords: TMEPAI; Tumorigenesis; Ubiquitination.

MeSH terms

  • Androgens* / metabolism
  • Animals
  • Carcinogenesis / metabolism
  • Male
  • Membrane Proteins / metabolism
  • Mice
  • NF-KappaB Inhibitor alpha / metabolism
  • NF-kappa B* / metabolism
  • Phosphorylation
  • Prostate / metabolism
  • Signal Transduction

Substances

  • NF-kappa B
  • NF-KappaB Inhibitor alpha
  • Androgens
  • Membrane Proteins